8-K Announcements
6Material company update
May 22, 2026·SEC
Material company update
May 12, 2026·SEC
Material company update
Mar 19, 2026·SEC
Tenon Medical, Inc.(TNON)Earnings, Financials & Key Ratios
TNON•NASDAQ
$0.51
Price updated Jun 27, 2026
AboutTenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and corresponding outcomes. It sells The CATAMARAN SIJ Fusion System that includes instruments and implants designed to prepare and fixate the SI-Joint for fusion in the United States and Puerto Rico. The company was founded in 2012 and is based in Los Gatos, California.Show more
- Revenue$4M+20.4%
- EBITDA-$13M+2.4%
- Net Income-$13M+8.2%
- EPS (Diluted)-1.70+84.9%
- Gross Margin59.79%+14.5%
- EBITDA Margin-324.34%+18.9%
- Operating Margin-324.34%+22.8%
- Net Margin-318.36%+23.7%
- ROE-228.06%+43.7%
TNON Price & Volume
Tenon Medical, Inc. (TNON) stock price & volume — 10-year historical chart
Loading chart...
Persistent Cash Burn Threatens Tenon Medical Solvency
Investment Thesis • Updated 2026Q1
VerdictNegative
Growth:Mixed
Profitability:Negative
Financial Position:Vulnerable
Cash Flow:Burning
Primary Risk:Imminent capital exhaustion risk
"Tenon Medical faces a precarious financial outlook characterized by structural operating losses and a rapidly depleting liquidity buffer. While the company achieved an 89.9% revenue growth rate in 2026Q1, this expansion is insufficient to offset quarterly SG&A expenses that consistently exceed $3 million. Investors should remain cautious as the company's reliance on debt financing and persistent negative free cash flow suggest an imminent risk of capital exhaustion."
Verdict Logic
the company's $4.6 million cash position as of 2026Q1 provides a narrow runway given the structural inability to achieve operating leverage against $3 million in quarterly SG&A costs.
TNON Growth Metrics
Tenon Medical, Inc. (TNON) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years145.95%
3 Years78.71%
TTM40.56%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM9.69%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM91.33%
Return on Capital
10 Years-535.77%
5 Years-535.77%
3 Years-226.16%
Last Year-164.83%
TNON Recent Earnings
Tenon Medical, Inc. (TNON) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 4/12 qtrs (33%)●Beat Revenue 3/12 qtrs (25%)
Q2 2026Latest
May 12, 2026Metric
Actual
Est
EPS
$0.31-1.6%
$0.30
Rev
$1M+6.4%
$1M
Q2 2026
Mar 19, 2026Metric
Actual
Est
EPS
$0.22+38.9%
$0.36
Rev
$2M+8.8%
$1M
Q4 2025
Nov 13, 2025Metric
Actual
Est
EPS
$0.40-11.1%
$0.36
Rev
$1M-14.9%
$1M
Q3 2025
Aug 13, 2025Metric
Actual
Est
EPS
$0.36+23.4%
$0.47
Rev
$564,000-38.0%
$909,500
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 12, 2026 | $0.31vs $0.30-1.6% | $1Mvs $1M+6.4% |
| Q2 2026 | Mar 19, 2026 | $0.22vs $0.36+38.9% | $2Mvs $1M+8.8% |
| Q4 2025 | Nov 13, 2025 | $0.40vs $0.36-11.1% | $1Mvs $1M-14.9% |
| Q3 2025 | Aug 13, 2025 | $0.36vs $0.47+23.4% | $564,000vs $909,500-38.0% |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for Tenon Medical, Inc. (TNON)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.51 | $3.78M | -0.30 | 20.35% | -318.36% | -228.06% | — | |
| $17.33 | $768.57M | -39.39 | 20.19% | -8.1% | -9.56% | — | |
| $9.30 | $1.41B | -9.69 | 24.95% | -21.07% | -443.09% | — | |
| $0.42 | $58.92M | 14.00 | 14.21% | 1.5% | 3.68% | — | |
| $86.25 | $11.63B | 22.00 | 16.65% | 18.92% | 13.04% | — | |
| $9.78 | $395.32M | -4.29 | 2.85% | -7.27% | -13.44% | — |
Compare TNON vs Peers
Tenon Medical, Inc. (TNON) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
TNON SEC Filings & Documents
Tenon Medical, Inc. (TNON) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when TNON posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
TNON Frequently Asked Questions
Tenon Medical, Inc. (TNON) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Tenon Medical, Inc.'s revenue?
Tenon Medical, Inc. (TNON) reported $4.6M in revenue for fiscal year 2025. This represents a 8506% increase from $0.1M in 2019.
How fast is Tenon Medical, Inc. growing?
Tenon Medical, Inc. (TNON) grew revenue by 20.4% over the past year. This is strong growth.
Is TNON profitable?
Tenon Medical, Inc. (TNON) reported a net loss of $12.4M for fiscal year 2025.
Dividend & Returns
What is TNON's return on equity?
Tenon Medical, Inc. (TNON) has a return on equity (ROE) of -228.1%. Negative ROE indicates the company is unprofitable.
What is Tenon Medical, Inc.'s free cash flow?
Tenon Medical, Inc. (TNON) had negative free cash flow of $11.6M in fiscal year 2025, likely due to heavy capital investments.